Latest filing published 03 Mar 2026 for Organogenesis Holdings Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
David Francisco: trading record in brief
This profile gathers the share dealings of David Francisco in Organogenesis Holdings Inc., where the filings describe the role as finance chief. Between 15 February 2021 and 18 February 2026, the trades on record add up to 26 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 3 March 2026, reports a share grant of €48k in Organogenesis Holdings Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to David Francisco
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 44,040 shares0Class A Common StockSEC:0002064832-26-000088:0
- 195,312 shares0Class A Common StockSEC:0002064832-26-000060:0
- 3,898 shares@ US$3.739.5% of flowClass A Common StockSEC:0002064832-26-000031:0
- 165,156 shares0Class A Common StockSEC:0001062993-25-003224:0
- 11,765 shares@ US$3.7035.8% of flowClass A Common StockSEC:0001062993-25-002931:0
- 160,350 shares0Class A Common StockSEC:0001062993-24-004314:0
- 18,966 shares@ US$3.6856.0% of flowClass A Common StockSEC:0001062993-24-003761:0
- 242,508 shares0Class A Common StockSEC:0001062993-23-004888:0
- 3,506 shares@ US$2.928.2% of flowClass A Common StockSEC:0001062993-23-004055:0
- 40,348 shares0Class A Common StockSEC:0001062993-22-004796:0
10 of 10 declarations
